SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-16-012158
Filing Date
2016-03-31
Accepted
2016-03-31 16:51:24
Documents
72

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.4 TO REGISTRATION STATEMENT posam42016maxim_soligenix.htm POS AM 1294187
2 SUBSIDIARIES OF THE COMPANY posam42016ex21imaxim_solig.htm EX-21.1 3398
3 CONSENT OF EISNERAMPER LLP posam42016ex23imaxim_solig.htm EX-23.1 1775
4 GRAPHIC image_001.jpg GRAPHIC 607
5 GRAPHIC image_002.jpg GRAPHIC 586
  Complete submission text file 0001213900-16-012158.txt   5425449

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20151231.xml EX-101.INS 952915
7 XBRL SCHEMA FILE sngx-20151231.xsd EX-101.SCH 50258
8 XBRL CALCULATION FILE sngx-20151231_cal.xml EX-101.CAL 37483
9 XBRL DEFINITION FILE sngx-20151231_def.xml EX-101.DEF 204609
10 XBRL LABEL FILE sngx-20151231_lab.xml EX-101.LAB 458114
11 XBRL PRESENTATION FILE sngx-20151231_pre.xml EX-101.PRE 338536
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-184762 | Film No.: 161543832
SIC: 2834 Pharmaceutical Preparations